Abstract
Background. To define the relationship between regional coronary vasodilator capacity and myocardial circumferential strain at rest in normal weight, overweight, and obese individuals with normal global left-ventricular function. Methods and Results. Myocardial blood flow at rest and during pharmacologic vasodilation was measured with 13N-ammonia PET/CT in mL/g/minute in normal weight control (CON, n = 12), overweight (OW, n = 10), and obese individuals (OB, n = 10). In addition, resting myocardial function was evaluated as circumferential strain (εc, %) by MRI. Global myocardial flow reserve (MFR) did not differ significantly between CON and OW (2.98 ± 0.96 vs 2.70 ± 0.66, P = .290), whereas it declined significantly in OB (1.98 ± 1.04, P = .030). Further, global εc (%) was comparable between CON, OW, and OB (20.24 ± 0.03, 20.23 ± 0.02, and 20.23 ± 0.04) but it was lowest in OB when normalized to the rate-pressure product (N εc: 20.31 ± 0.06, 20.32 ± 0.05, and 20.26 ± 0.08). When MFR of the three major coronary territories was correlated with corresponding εc, a positive association was observed in CON (r = 0.36, P = .030), in OW (r = 0.54, P = .002), and also in OB when relating N εc to coronary vascular resistance during pharmacologic vasodilation (r = 20.46, P = .010). Conclusions. Higher coronary vasodilator capacity is related to corresponding regional circumferential strain at rest in non-obese individuals, while this is also observed for reduced MFR in obesity.
| Original language | English |
|---|---|
| Pages (from-to) | 693-703 |
| Number of pages | 11 |
| Journal | Journal of Nuclear Cardiology |
| Volume | 19 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Aug 2012 |
| Externally published | Yes |
Bibliographical note
Funding Information:Financial support: Research Grants 3200B0-122237 from the Swiss National Science Foundation (SNF), with contributions of the Clinical Research Center, University Hospital and Faculty of Med-icine, Geneva and the Louis-Jeantet Foundation, Swiss Heart Foundation, and Fellowship Grants from the European Society of Cardiology (ESC) and the Italian Society of Cardiology (Societa‘ Italiana di Cardiologia; SIC) (G.V.).